Medical Information
Ireland
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a healthcare professionalYes, I am a healthcare professional
SelectI am a healthcare professionalYes, I am a healthcare professional
I am a Patient/Caregiver or
Member of the General PublicNo, go back to the patient portal
SelectI am a Patient/Caregiver or
Member of the General PublicNo, go back to the patient portal

If you don't reside in Ireland, please click here

The medical information on this site is intended only for healthcare professionals in the Republic of Ireland. The products discussed herein may have different product labeling in other countries.

This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Poster
Ramirez JA, Carrico R, Wilde A, Junkins A, Furmanek S, Chandler T, Schulz P, Hubler R, Peyrani P, Trivedi S, Liu Q, Uppal S, Gessner B, Begier E, and the NIDI RSV Study Group October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

Adding sputum and saliva to nasopharyngeal swab samples for PCR detection of Respiratory Syncytial Virus in adults hospitalized with acute respiratory illness may double case detection

View Presentation
Oral Presentation
Walsh E, Polack F, Zareba AM, Falsey A, Marc GP, Jiang Q, Schneider K, Cooper D, Lino MM, Anderson A, Jansen KU, Swanson K, Gurtman A, Gruber W, Schmoele-Thoma B for the RENOIR Clinical Trial Group October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

Efficacy and Safety of Bivalent Respiratory Syncytial Virus (RSVpreF) Vaccine in Older Adults

View Presentation
Oral Presentation
Simões EAF, Madhi S, Paeds. F.C., Center KJ, Llapur C, Pizarro JN, Swanson KA, Radley D, McGrory SB, Gomme E, Scott DA, Jansen KU, Gruber WC, Gurtman AC October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

Establishing Proof of Concept for a Bivalent RSVpreF Subunit Vaccine for Maternal Immunization

View Presentation
Poster
Law AW, Judy J, Willis SJ, Shea KM October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

High Maternal Tdap Vaccine Uptake During Early Part of Vaccination Window: Implications for Future Maternal Vaccines

View Presentation
Poster
Weycker D, Averin A, Houde L, Ottino K, Shea K, Gessner BD, Yacisin K, Curcio D, Begier B, Rozenbaum M October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

Rates of Lower Respiratory Tract Infections Among US Adults Aged ≥18 Years with and without Chronic Medical Conditions

View Presentation
Poster
McLaughlin JM, Khan F, Begier E, Swerdlow DL, Jodar L, andFalsey AR October 23, 2022 IDWEEK 2022 Respiratory Syncytial Virus

Rates of Medically-Attended RSV among US Adults: A Systematic Review and Meta-Analysis

View Presentation